昭和大学藤が丘病院における抗ＭＲＳＡ薬の適正使用へ向けたＩＣＴの取り組み
書誌事項
- タイトル別名
-
- Action by Infection Control Team to Ensure Proper Usage of Anti-MRSA Medicines in Showa University Fujigaoka Hospital
この論文をさがす
説明
The infection control team at Showa University Fujigaoka Hospital placed a formulary restriction on physicians’use of anti-methicillin resistant Staphylococcus aureus (MRSA) agents (vancomycin,arbekacin and teicoplanin) in January 2004.To evaluate the effect of this restriction,we investigated the changes in numbers of vials of anti-MRSA agents used between 1 year before and 1 year after the restriction was implemented,and in the numbers of new MRSA-positive inpatients (newly registered inpatients with MRSA infection or contamination).<br>There was a significant decrease in monthly vial consumption for intravenous (iv) and oral vancomycins.This was accompanied by a 66% decrease in the cost of vancomycins used.However,there was no increase in the number of newly registered MRSA-positive inpatients over this period.There was also no significant change in monthly vial consumption for the newer anti-MRSA agents,arbekacin and teicoplanin,which was because the number of prescriptions of these drugs was much smaller than that for vancomycins.<br>By hospital department,there was a remarkable decrease in iv and oral vancomycin usage in Gastroenterology and in the use of iv vancomycins in Chest Surgery.However,there was no significant decrease in newly registered MRSA-positive patients in these 2 departments.<br>These findings suggest that such a formulary restriction contributes to ensuring the proper usage of anti-MRSA agents for inpatients with MRSA infections as well as to reducing medical costs.
収録刊行物
-
- 医療薬学
-
医療薬学 33 (7), 607-612, 2007
一般社団法人日本医療薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204776070272
-
- NII論文ID
- 110006345260
-
- NII書誌ID
- AA11527197
-
- ISSN
- 18821499
- 1346342X
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- Crossref
- NDLデジコレ（旧NII-ELS）
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可
